Chemours CC Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $670M-6.0% | $713M-40.7% | $1.2B+9.2% | $1.1B-24.1% | ||
| $2M— | $0-100% | $604M+199% | $202M+102% | ||
| $679M-11.8% | $770M+23.8% | $622M-0.6% | $626M-13.1% | ||
| $1.57B+7.2% | $1.46B+8.5% | $1.35B-3.9% | $1.4B+27.8% | ||
| $80M+12.7% | $71M+7.6% | $66M-19.5% | $82M+9.3% | ||
| $3B-0.5% | $3.02B-21.5% | $3.84B+19.6% | $3.21B-3.9% | ||
| $3.08B-3.5% | $3.19B-0.6% | $3.21B+1.1% | $3.17B+0.5% | ||
| $6.84B+7.1% | $6.39B+3.0% | $6.21B-0.2% | $6.22B+2.3% | ||
| $271M+2.3% | $265M+0.8% | $263M+9.6% | $240M+5.7% | ||
| $46M0.0% | $46M-54.9% | $102M0.0% | $102M0.0% | ||
| $2M-33.3% | $3M0.0% | $3M-76.9% | $13M+117% | ||
| $751M-4.7% | $788M+18.7% | $664M+27.0% | $523M+17.0% | ||
| $160M+5.3% | $152M-3.8% | $158M-9.7% | $175M+3.6% | ||
| $7.38B-1.7% | $7.51B-8.9% | $8.24B+7.9% | $7.64B+1.2% | ||
| $954M-17.5% | $1.16B-0.3% | $1.16B-6.0% | $1.23B+6.1% | ||
| $96M-3.0% | $99M+11.2% | $89M-26.4% | $121M-30.1% | ||
| $42M-22.2% | $54M+5.9% | $51M+18.6% | $43M+72.0% | ||
| $62M+10.7% | $56M+1.8% | $55M+12.2% | $49M-16.9% | ||
| $1.69B-7.4% | $1.82B-26.8% | $2.49B+31.5% | $1.89B+1.8% | ||
| $37M+5.7% | $35M-20.5% | $44M-27.9% | $61M+24.5% | ||
| $4.1B+1.0% | $4.06B+1.8% | $3.99B+11.1% | $3.59B-3.6% | ||
| $191M-3.5% | $198M-4.8% | $208M+5.1% | $198M+10.6% | ||
| $39M-23.5% | $51M-12.1% | $58M-4.9% | $61M-15.3% | ||
| $588M+59.3% | $369M+12.2% | $329M+3.1% | $319M+18.6% | ||
| $7.13B+2.8% | $6.94B-7.7% | $7.52B+15.1% | $6.53B+1.0% | ||
| $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | ||
| $1.07B+1.8% | $1.06B+2.1% | $1.03B+1.7% | $1.02B+7.6% | ||
| $1.22B-27.6% | $1.69B-5.4% | $1.78B-17.9% | $2.17B+24.3% | ||
| -$244M+33.5% | -$367M-33.9% | -$274M+20.1% | -$343M+5.8% | ||
| $1.8B-0.1% | $1.8B-0.1% | $1.81B+3.9% | $1.74B+39.4% | ||
| $1M0.0% | $1M-50.0% | $2M— | —— | ||
| $250M-56.2% | $571M-20.8% | $721M-34.9% | $1.11B+2.4% | ||
| $7.38B-1.7% | $7.51B-8.9% | $8.24B+7.9% | $7.64B+1.2% | ||
| $751M-4.7% | $788M+18.7% | $664M+27.0% | $523M+17.0% | ||
| $271M+2.3% | $265M+0.8% | $263M+9.6% | $240M+5.7% | ||
| $271M+2.3% | $265M+0.8% | $263M+9.6% | $240M+5.7% | ||
| $751M-4.7% | $788M+18.7% | $664M+27.0% | $523M+17.0% | ||
| $2M-33.3% | $3M0.0% | $3M-76.9% | $13M+117% | ||
| $9.92B+3.6% | $9.58B+1.8% | $9.41B+0.3% | $9.39B+1.7% | ||
| $271M+2.3% | $265M+0.8% | $263M+9.6% | $240M+5.7% | ||
| $751M-4.7% | $788M+18.7% | $664M+27.0% | $523M+17.0% | ||
| $88M-23.5% | $115M-10.9% | $129M-33.5% | $194M+12.1% | ||
| $96M-3.0% | $99M+11.2% | $89M-26.4% | $121M-30.1% | ||
| $506M+27.8% | $396M-62.6% | $1.06B+253% | $300M-7.7% | ||
| $506M+27.8% | $396M-62.6% | $1.06B+253% | $300M-7.7% | ||
| $96M-3.0% | $99M+11.2% | $89M-26.4% | $121M-30.1% | ||
| $530M+16.2% | $456M-1.1% | $461M-2.7% | $474M+21.9% | ||
| $4.43B+0.5% | $4.41B+1.2% | $4.36B+10.6% | $3.94B-2.9% | ||
| $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | ||
| $9.92B+3.6% | $9.58B+1.8% | $9.41B+0.3% | $9.39B+1.7% | ||
| $88M-23.5% | $115M-10.9% | $129M-33.5% | $194M+12.1% | ||
| $42M-22.2% | $54M+5.9% | $51M+18.6% | $43M+72.0% | ||
| $37M+5.7% | $35M-20.5% | $44M-27.9% | $61M+24.5% | ||
| $160M+5.3% | $152M-3.8% | $158M-9.7% | $175M+3.6% | ||
| $1M0.0% | $1M-50.0% | $2M— | —— | ||
| $80M+12.7% | $71M+7.6% | $66M-19.5% | $82M+9.3% | ||
| $1M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Chemours cover its short-term obligations?
- Its current ratio is 1.82 — current assets exceed current liabilities.
- Where does Chemours's balance sheet data come from?
- Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.